Skip to main content

Deze website is uitsluitend voorbehouden aan beroepsbeoefenaren in Nederland.

accelRare image

3.5-5.9% of your patients may have a rare disease - but the diagnostic journey takes up to 10 years.1,2

Why? Rare diseases present with heterogeneous symptoms that overlap common conditions, and most HCPs see only a handful of cases in their entire career. accelRare® helps you identify which patients warrant further rare disease investigation - earlier in their journey.

Coverage


310 rare diseases

Validation


89% diagnostic reliability

Time investment


~10 minutes per case

Cost


Free of charge

1/4

Coverage


310 rare diseases

Validation


89% diagnostic reliability

Time investment


~10 minutes per case

Cost


Free of charge

1/2

How does accelRare® work?

You as a physician can fill in:

  • Your patient's clinical symptoms
  • Relevant medical history
  • Available test results

Based on the input accelRare® provides 4 key elements to accelerate the pre-diagnoses:

  • Differential diagnosis list - ranked rare diseases to consider
  • Disease descriptions - key clinical features and presentations
  • Potential next steps - additional tests to perform
  • Referral pathways - specialist centres for definitive diagnosis

Clinical Validation & Reliability

  • Developed with 67 European rare disease experts
  • 89% reliability in identifying rare disease candidates
  • Covers 310 rare diseases across multiple specialties
  • Tested in real-world clinical scenarios

When to Use accelRare®

Consider using accelRare® when:

  • Patient has unexplained symptoms despite standard workup
  • Multiple organ systems are involved
  • Symptoms began in childhood or have been chronic
  • Family history suggests genetic component
  • Standard differential diagnosis hasn't led to answers

Not a replacement for: clinical judgment, specialist consultation, or definitive diagnostic testing.

ACCELRARE LOGO
MEDVIR LOGO
  • accelRare® is a pre-diagnostic digital solution for rare diseases.

  • accelRare® uses the medvir tool, certified as a Class I medical device in EU, for which Medical Intelligence Service is the manufacturer and Sanofi the distributor.

Neem contact op

Get in touch - dupixent
Wij staan klaar

Heeft u vragen of wilt u meer weten? Wij zorgen dat u zo snel mogelijk geholpen wordt.

MAT-BE-2600259 v1.0 02/2026